SeaStar Medical (NASDAQ:ICU – Get Free Report) is one of 232 public companies in the “Surgical & medical instruments” industry, but how does it weigh in compared to its peers? We will compare SeaStar Medical to related companies based on the strength of its dividends, earnings, institutional ownership, profitability, risk, analyst recommendations and valuation.
Institutional and Insider Ownership
1.7% of SeaStar Medical shares are owned by institutional investors. Comparatively, 48.2% of shares of all “Surgical & medical instruments” companies are owned by institutional investors. 4.5% of SeaStar Medical shares are owned by insiders. Comparatively, 15.4% of shares of all “Surgical & medical instruments” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Valuation and Earnings
This table compares SeaStar Medical and its peers revenue, earnings per share (EPS) and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
SeaStar Medical | N/A | -$26.23 million | -0.37 |
SeaStar Medical Competitors | $1.04 billion | $4.09 million | 1.54 |
Analyst Ratings
This is a summary of recent ratings and price targets for SeaStar Medical and its peers, as reported by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
SeaStar Medical | 0 | 0 | 0 | 0 | N/A |
SeaStar Medical Competitors | 1605 | 4333 | 8507 | 223 | 2.50 |
As a group, “Surgical & medical instruments” companies have a potential upside of 25.03%. Given SeaStar Medical’s peers higher probable upside, analysts plainly believe SeaStar Medical has less favorable growth aspects than its peers.
Risk and Volatility
SeaStar Medical has a beta of -0.96, meaning that its share price is 196% less volatile than the S&P 500. Comparatively, SeaStar Medical’s peers have a beta of 1.07, meaning that their average share price is 7% more volatile than the S&P 500.
Profitability
This table compares SeaStar Medical and its peers’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
SeaStar Medical | N/A | N/A | -741.57% |
SeaStar Medical Competitors | -737.35% | -146.92% | -29.30% |
Summary
SeaStar Medical peers beat SeaStar Medical on 8 of the 10 factors compared.
About SeaStar Medical
SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.
Receive News & Ratings for SeaStar Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaStar Medical and related companies with MarketBeat.com's FREE daily email newsletter.